Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 168,105 | 285,442 | 263,099 | 139,585 | 229,296 |
| Depreciation Amortization | 111,711 | 107,238 | 101,069 | 87,747 | 82,737 |
| Income taxes - deferred | -39,447 | -29,567 | 6,816 | -27,431 | 13,130 |
| Accounts receivable | -20,533 | -20,867 | -57,596 | -15,549 | 6,556 |
| Accounts payable and accrued liabilities | 25,769 | -7,908 | 12,741 | 19,091 | 10,343 |
| Other Working Capital | -10,106 | -90,577 | -69,517 | 29,263 | -5,246 |
| Other Operating Activity | 63,482 | 10,632 | 68,660 | 119,458 | -131,599 |
| Operating Cash Flow | $298,981 | $254,393 | $325,272 | $352,164 | $205,217 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 22,557 | 14,736 | -26,943 | 26,693 | 76,933 |
| PPE Investments | -62,877 | -38,244 | -44,908 | -44,301 | -51,744 |
| Net Acquisitions | -169,707 | -101,184 | N/A | -225,352 | N/A |
| Purchase Of Investment | 6,997 | -232,000 | -25,000 | -556 | 1,906 |
| Sale Of Investment | 0 | 91,043 | 0 | 0 | N/A |
| Investing Cash Flow | $-203,030 | $-265,649 | $-96,851 | $-243,516 | $27,095 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 225,000 | 619,661 | 90,000 | 256,000 | 40,000 |
| Debt Repayment | -256,000 | -525,661 | -175,500 | -271,500 | N/A |
| Common Stock Issued | 60,935 | 29,813 | 77,155 | 65,092 | 70,983 |
| Common Stock Repurchased | -80,042 | -19,562 | -160,950 | -43,178 | -50,112 |
| Dividend Paid | -50,419 | -50,285 | -50,185 | -49,622 | -48,902 |
| Other Financing Activity | -21,872 | -31,350 | -23,373 | -19,343 | -195,771 |
| Financing Cash Flow | $-122,398 | $22,616 | $-242,853 | $-62,551 | $-183,802 |
| Exchange Rate Effect | -2,333 | -3,356 | -12,092 | 6,369 | -2,771 |
| Beginning Cash Position | 180,571 | 172,567 | 199,091 | 146,625 | 100,886 |
| End Cash Position | 151,791 | 180,571 | 172,567 | 199,091 | 146,625 |
| Net Cash Flow | $-28,780 | $8,004 | $-26,524 | $52,466 | $45,739 |
| Free Cash Flow | |||||
| Operating Cash Flow | 298,981 | 254,393 | 325,272 | 352,164 | 205,217 |
| Capital Expenditure | -62,877 | -38,244 | -44,908 | -44,301 | -51,744 |
| Free Cash Flow | 236,104 | 216,149 | 280,364 | 307,863 | 153,473 |